The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection

Viral Immunology

Volumn 25, Issue 2, 2012, Pages 166-172

  Jablonowska, Elzbieta ^a   Wojcik, Kamila ^a   Nocun, Marek ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; L SELECTIN; PEGINTERFERON ALPHA2A; REACTIVE OXYGEN METABOLITE; RIBAVIRIN;

ADULT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; MOLECULE; NECROSIS; NEUTROPHIL; TREATMENT DURATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD; ANTIVIRAL AGENTS; APOPTOSIS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RIBAVIRIN; VIRAL LOAD;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84859585360     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0078     Document Type: Article

References (29)

1. Benhamou Y, Bochet M, Di Martino V, et al.: Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999;30:1054-1058. (Pubitemid 29458296)
2. Cascao R, Rosario HS, and Fonseca JE: Neutrophils: Warriors and commanders in immune mediated inflammatory diseases. Acta Reumatol Port 2009;34:313-326.
3. Chaudhri G, and Clark IA: Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol 1989;143:1290-1294. (Pubitemid 19211363)
4. Chen Q, Gong B, Mahmoud-Ahmed AS, et al.: Apo2L/ TRAIL and Bcl-2-related proteins regulate type I interferoninduced apoptosis in multiple myeloma. Blood 2001;98: 2183-2192.
5. Chen TP, Roberts RL, Wu KG, Ank BJ, and Stiehm ER: Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediatr Res 1993;34:544-550. (Pubitemid 23297188)
6. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, and Ou JH: Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 2004;39: 81-89. (Pubitemid 38461470)
7. De Maria N, Colantoni A, Fagiuoli S, et al.: Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291-295. (Pubitemid 26271718)
8. Elbim C, Pillet S, Prevost MH, et al.: The role of phagocytes in HIV-related oxidative stress. J Clin Virol 2001;20: 99-109. (Pubitemid 32106863)
9. Farinati F, Cardin R, De Maria N, et al.: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995;22:449-456.
10. Fialkow L, Wang Y, and Downey GP: Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007;42:153-164. (Pubitemid 46001554)
11. Giorgini A, Capsoni F, Podda M, et al.: Treatment with PEGinterferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis. Ann NY Acad Sci 2009;1173:847-857.
12. Gougerot-Pocidalo MA, Roche Y, Fay M, Perianin A, and Bailly S: Oxidative injury amplifies interleukin-1-like activity produced by human monocytes. Int J Immunopharmacol 1989;11:961-969. (Pubitemid 20011308)
13. Israel N, Hazan U, Alcami J, et al.: Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J Immunol 1989;143:3956-3960. (Pubitemid 20012579)
14. Jablonowska E, Tchorzewski H, Lewkowicz P, and Kuydowicz J: Reactive oxygen intermediates and serum antioxidative system in patients with chronic C hepatitis treated with IFN-alpha and thymus factor X. Arch Immunol Ther Exp (Warsz) 2005;53:529-533. (Pubitemid 43035781)
15. Jablonowska E, Wojcik, Kur B, Lewkowicz P, and Nocun M: Neutrophil function and apoptosis in patients with chronic hepatitis C treated with pegylated interferon a and ribavirin. Arch Immunol Ther Exp (Warsz) 2012;60:61-68.
16. Labarga P, Vispo E, Barreiro P, et al.: Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C virus coinfected patients with prior nonresponse or relapse. J Acquir Immune Defic Syndr 2010; 53:364-368.
17. Little R, White MR, and Hartshorn KL: Interferon-alpha enhances neutrophil respiratory burst responses to stimulation with influenza A virus and FMLP. J Infect Dis 1994;170: 802-810.
18. Martin-Carbonero L, Benhamou Y, Puoti M, et al.: Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: A European collaborative study. Clin Infect Dis 2004;38:128-133. (Pubitemid 38045883)
19. Melley DD, Evans TW, and Quinlan GJ: Redox regulation of neutrophil apoptosis and the systemic inflammatory response syndrome. Clin Sci (Lond) 2005;108:413-424. (Pubitemid 40685671)
20. Murphy PM, Lane HC, Fauci AS, and Gallin JI: Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988;158:627-630.
21. Nielsen H, Kharazmi A, and Faber V: Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand J Immunol 1986;24:291-296. (Pubitemid 16021927)
22. Nunez M, Miralles C, Berdun MA, et al.: Role of weightbased ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: The PRESCO trial. AIDS Res Hum Retroviruses 2007;23:972-982. (Pubitemid 47492337)
23. Platanias LC: Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 2005;5:375-386.
24. Rockstroh JK, Mocroft A, Soriano V, et al.: Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005;192:992-1002. (Pubitemid 41266795)
25. Schwartz R, Lu Y, Villines D, and Sroussi HY: Effect of human immunodeficiency virus infection on S100A8/A9 inhibition of peripheral neutrophils oxidative metabolism. Biomed Pharmacother 2010;64:572-575.
26. Soriano V, Sulkowski M, Bergin C, et al.: Care of patients with chronic hepatitis C and HIV co-infection: Recommendations from the HIV-HCV International Panel. AIDS 2002; 16:813-828. (Pubitemid 34409005)
27. Stark GR: How cells respond to interferons revisited: From early history to current complexity. Cytokine Growth Factor Rev 2007;18:419-423. (Pubitemid 47302834)
28. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al.: Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438-450. (Pubitemid 38988593)
29. Valone FH, Payan DG, Abrams DI, and Goetzl EJ: Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis 1984;150:267-271. (Pubitemid 14073368)